Companies Dominating the Thoracic Vascular Stent Grafts Landscape
- Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- JOTEC GmbH
- Cook Group Incorporated
- Terumo Corporation
- Cardinal Health, Inc.
- LeMaitre Vascular, Inc.
- Merit Medical Systems, Inc.
- Lombard Medical Ltd
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Endologix LLC
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of thoracic vascular stent grafts is estimated at USD 241.24 million.
The thoracic vascular stent grafts market size was valued at USD 219.31 million in 2024 and is likely to cross USD 473.54 million by 2037, registering more than 6.1% CAGR during the forecast period i.e., between 2025-2037. Increasing geriatric population, growing cases of hypertension, increasing consumption of tobacco, and upsurge in fast food consumption will drive the market growth.
North America industry is predicted to hold largest revenue share by 2037, attributed to significant rise in the aged population, coupled with the high prevalence of cardiovascular diseases (CVDs) in the region.
The major players in the market are Medtronic plc, JOTEC GmbH, Cook Group Incorporated, Terumo Corporation, Cardinal Health, Inc., LeMaitre Vascular, Inc., Merit Medical Systems, Inc., Lombard Medical Ltd, Lifetech Scientific (Shenzhen) Co., Ltd., Endologix LLC
